Patents by Inventor Jelle Slootstra

Jelle Slootstra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070128217
    Abstract: The present invention pertains to antigenic peptides of SARS-CoV and their use in diagnostic test methods and in the treatment of condition resulting from SARS-CoV. Furthermore, this invention provides antibodies capable of specifically recognizing the peptides of the invention. The antibodies can also advantageously be used in diagnostic test methods and in the treatment of condition resulting from SARS-CoV.
    Type: Application
    Filed: January 13, 2006
    Publication date: June 7, 2007
    Applicant: Crucell Holland B.V.
    Inventors: Jan ter Meulen, Jaap Goudsmit, Jelle Slootstra, Peter Timmerman, Cornelis de Kruif, Edward van den Brink
  • Publication number: 20070099240
    Abstract: The invention relates to the detection of biomolecules or analogs of the biomolecules in micro-arrays and the supports used for the micro-arrays. Methods for determining or testing binding of a first member molecule within an array or library of tentative first member binding molecules for binding with a second member binding molecule are disclosed. A support for a micro-array suitable for determining binding of a first member molecule within a library of spots of tentative first member binding molecules with a second member binding molecule is disclosed. The support includes a support surface wherein surface patches are interspersed within surface areas that are materially distinct from the patches.
    Type: Application
    Filed: November 10, 2006
    Publication date: May 3, 2007
    Inventors: Wouter Puijk, Evert van Dijk, Jelle Slootstra
  • Publication number: 20060154243
    Abstract: The present invention pertains to antigenic peptides of SARS-CoV and their use in diagnostic test methods and in the treatment of condition resulting from SARS-CoV. Furthermore, this invention provides antibodies capable of specifically recognizing the peptides of the invention. The antibodies can also advantageously be used in diagnostic test methods and in the treatment of conditions resulting from SARS-CoV.
    Type: Application
    Filed: January 20, 2006
    Publication date: July 13, 2006
    Inventors: Jan Ter Meulen, Jaap Goudsmit, Peter Timmerman, Jelle Slootstra
  • Publication number: 20060110803
    Abstract: The present invention pertains to antigenic peptides of SARS-CoV and their use in diagnostic test methods and in the treatment of condition resulting from SRAS-CoV. Furthermore, this invention provides antibodies capable of specifically recognizing the peptides of the invention. The antibodies can also advantageously be used in diagnostic test methods and in the treatment of condition resulting from SRAS-CoV.
    Type: Application
    Filed: December 6, 2005
    Publication date: May 25, 2006
    Applicant: Crucell Holland B.V.
    Inventors: Jan Ter Meulen, Jaap Goudsmit, Wouter Puijk, Jelle Slootstra, Peter Timmerman